CME Group Inc (NASDAQ:CME) Insider Kevin Kometer Sells 16,140 Shares

CME Group Inc (NASDAQ:CME) insider Kevin Kometer sold 16,140 shares of CME Group stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $201.19, for a total transaction of $3,247,206.60. Following the completion of the transaction, the insider now directly owns 72,122 shares of the company’s stock, valued at approximately $14,510,225.18. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

NASDAQ CME opened at $198.75 on Wednesday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.16. The stock has a market cap of $72.16 billion, a PE ratio of 29.14, a P/E/G ratio of 4.65 and a beta of 0.24. CME Group Inc has a 52-week low of $158.35 and a 52-week high of $204.56.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.02. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The business had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same quarter in the previous year, the company earned $1.86 EPS. The business’s revenue was up 6.4% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc will post 6.59 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.51%. The ex-dividend date is Friday, June 7th. CME Group’s dividend payout ratio (DPR) is 43.99%.

A number of institutional investors have recently modified their holdings of the business. Berman Capital Advisors LLC raised its stake in CME Group by 23.9% in the 1st quarter. Berman Capital Advisors LLC now owns 342 shares of the financial services provider’s stock worth $56,000 after purchasing an additional 66 shares in the last quarter. Dubuque Bank & Trust Co. raised its stake in CME Group by 83.1% in the 1st quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 69 shares in the last quarter. Front Barnett Associates LLC raised its stake in CME Group by 5.4% in the 4th quarter. Front Barnett Associates LLC now owns 1,433 shares of the financial services provider’s stock worth $267,000 after purchasing an additional 73 shares in the last quarter. Van Hulzen Asset Management LLC raised its stake in CME Group by 3.9% in the 4th quarter. Van Hulzen Asset Management LLC now owns 2,012 shares of the financial services provider’s stock worth $378,000 after purchasing an additional 76 shares in the last quarter. Finally, ETF Managers Group LLC raised its stake in CME Group by 9.5% in the 1st quarter. ETF Managers Group LLC now owns 898 shares of the financial services provider’s stock worth $148,000 after purchasing an additional 78 shares in the last quarter. Institutional investors and hedge funds own 84.76% of the company’s stock.

A number of research firms have recently issued reports on CME. UBS Group raised their target price on shares of CME Group from $175.00 to $190.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 5th. Zacks Investment Research cut shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 target price for the company. in a research note on Monday, May 27th. Citigroup set a $205.00 target price on shares of CME Group and gave the stock a “buy” rating in a research note on Friday, February 15th. BidaskClub upgraded shares of CME Group from a “strong sell” rating to a “sell” rating in a research note on Wednesday, April 3rd. Finally, JPMorgan Chase & Co. began coverage on shares of CME Group in a research note on Friday, February 15th. They set an “underweight” rating and a $164.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and eight have issued a buy rating to the company. CME Group has an average rating of “Hold” and a consensus target price of $188.87.

ILLEGAL ACTIVITY NOTICE: This report was posted by WKRB News and is the property of of WKRB News. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.wkrb13.com/2019/06/12/cme-group-inc-nasdaqcme-insider-kevin-kometer-sells-16140-shares.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: How Important is Technical Analysis of Stocks

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.